CFD Research licenses bio-battery technology from Akermin
Nov 26, 2012 - US technology firm CFD Research Corp (CFDRC) today said it had licensed enzymatic cathode technology from Akermin Inc in a move that bolstered the company's bio-battery product line.
The bio-battery developed by Huntsville, Alabama-based CFDRC represents an ultra-high energy density fuel cell that uses biological enzymes as catalysts. The device turns fuels such as sugars, alcohols and even blood into electrical energy in a way similar to that food is converted into energy in human organisms, the company says. At the centre of the bio-battery is a nanocomposite anode containing enzymes that can oxidise glucose and other fuels, thus releasing electrons and producing energy. The technology of Akermin also uses enzymes to reduce oxygen, however, on the cathode side.
"Integrating our technologies will result in a high performing fully enzymatic fuel cell system and allow us to bring this game changing technology to market," said Sameer Singhal, CFDRC director of bio and energy technologies.
Akermin president and chief executive Barry Blackwell said the licensing agreement would allow Akermin to concentrate on another part of its platform technology, namely the use of a biocatalyst-driven system to manage carbon dioxide in industrial plants.
CFDRC says the bio-battery has many civilian and military applications, including reducing the number of batteries carried by soldiers, as well as remote monitoring, off-grid power and disaster relief.